HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC Anthrax MedKit Development Relies On Incremental Approach

This article was originally published in The Tan Sheet

Executive Summary

HHS’ Biomedical Advanced Research and Development Authority will ask FDA and its advisors about the feasibility of an OTC antibiotic MedKit for anthrax treatment at an advisory committee meeting.

You may also be interested in...

Acetaminophen Panel Recommends Standardizing Solid Dose Strength

A joint advisory panel recommended FDA consider standardizing chewable children's acetaminophen products to one strength.

FDA Panel To Influenza Home MedKit Sponsors: Get Real

Roche begins label comprehension studies this month to support development of aTamiflu home MedKit for the treatment or prophylaxis of pandemic influenza virus, under an initiative driven by the Department of Health and Human Services

Pandemic Flu Home MedKits Headed To NDAC/Antiviral Joint Panel

FDA's next advisory panel meeting on nonprescription drugs will consider the pre-deployment of antiviral influenza drug "MedKits" in preparation for a possible pandemic


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts